{"data":{"id":"us-nc/n.c.-gen.-stat.-90-113.75e","jurisdiction":"us-nc","citation":"N.C. Gen. Stat. § 90-113.75E","heading":"Opioid and Prescription Drug Abuse Advisory Committee; statewide strategic plan.","body":"(a)\tThere is hereby created the Opioid and Prescription Drug Abuse Advisory Committee, to be housed in and staffed by the Department. The Committee shall develop and, through its members, implement a statewide strategic plan to combat the problem of opioid and prescription drug abuse. The Committee shall include representatives from the following, as well as any other persons designated by the Secretary of Health and Human Services:\n(1)\tThe Department's Division of Health Benefits.\n(2)\tThe Department's Division of Mental Health, Developmental Disabilities, and Substance Use Services.\n(3)\tThe Department's Division of Public Health.\n(4)\tThe Office of Rural Health. Department's\n(5)\tThe Division of Juvenile Justice of the Department of Public Safety.\n(5a)\tThe Division of Community Supervision and Reentry of the Department of Adult Correction.\n(5b)\tThe Division of Prisons of the Department of Adult Correction.\n(6)\tThe State Bureau of Investigation.\n(7)\tThe Attorney General's Office.\n(8)\tThe following health care regulatory boards with oversight of prescribers and dispensers of opioids and other prescription drugs:\na.\tNorth Carolina Board of Dental Examiners.\nb.\tNorth Carolina Board of Nursing.\nc.\tNorth Carolina Board of Podiatry Examiners.\nd.\tNorth Carolina Medical Board.\ne.\tNorth Carolina Board of Pharmacy.\nf.\tNorth Carolina Veterinary Medical Board\n(9)\tThe UNC Injury Prevention Research Center.\n(10)\tThe substance abuse treatment community.\n(11)\tGovernor's Institute on Substance Abuse, Inc.\n(12)\tThe Department of Insurance's drug take-back program.\nAfter developing the strategic plan, the Committee shall be the State's steering committee to monitor achievement of strategic objectives and receive regular reports on progress made toward reducing opioid and prescription drug abuse in North Carolina.\n(b)\tIn developing the statewide strategic plan to combat the problem of opioid and prescription drug abuse, the Opioid and Prescription Drug Abuse Advisory Committee shall, at a minimum, complete the following steps:\n(1)\tIdentify a mission and vision for North Carolina's system to reduce and prevent opioid and prescription drug abuse.\n(2)\tScan the internal and external environment for the system's strengths, weaknesses, opportunities, and challenges (a SWOC analysis).\n(3)\tCompare threats and opportunities to the system's ability to meet challenges and seize opportunities (a GAP analysis).\n(4)\tIdentify strategic issues based on SWOC and GAP analyses.\n(5)\tFormulate strategies and resources for addressing these issues.\n(c)\tThe strategic plan for reducing opioid and prescription drug abuse shall include three to five strategic goals that are outcome-oriented and measureable. Each goal must be connected with objectives supported by the following five mechanisms of the system:\n(1)\tOversight and regulation of prescribers and dispensers by State health care regulatory boards.\n(2)\tOperation of the Controlled Substances Reporting System.\n(3)\tOperation of the Medicaid lock-in program to review behavior of patients with high use of prescribed controlled substances.\n(4)\tEnforcement of State laws for the misuse and diversion of controlled substances.\n(5)\tAny other appropriate mechanism identified by the Committee.\n(d)\tThe Department, in consultation with the Opioid and Prescription Drug Abuse Advisory Committee, shall develop and implement a formalized performance management system that connects the goals and objectives identified in the statewide strategic plan to operations of the Controlled Substances Reporting System and Medicaid lock-in program, law enforcement activities, and oversight of prescribers and dispensers. The performance management system must be designed to monitor progress toward achieving goals and objectives and must recommend actions to be taken when performance falls short.\n(e)\tBeginning on December 1, 2016, and annually thereafter, the Department shall submit an annual report on the performance of North Carolina's system for monitoring opioid and prescription drug abuse to the Joint Legislative Oversight Committee on Health and Human Services, the Joint Legislative Oversight Committee on Justice and Public Safety, and the Fiscal Research Division. (2015-241, s. 12F.16(m)-(q); 2015-268, s. 4.5; 2017-57, s. 11F.10; 2018-76, s. 9; 2019-81, s. 15(a); 2021-180, s. 19C.9(iii); 2023-65, s. 5.2(b).)","path":["Chapter 90. Medicine and Allied Occupations.","Article 5E. North Carolina Controlled Substances Reporting System Act."],"source_url":"https://www.ncleg.gov/EnactedLegislation/Statutes/HTML/BySection/Chapter_90/GS_90-113.75E.html","current_through":"S.L. 2026-30","vintage":"","retrieved_at":"2026-08-27T18:12:48Z","sha256":"cb0cfa6aeedf896ec1083778ad0c3731c3f589b17447bb09b78673d33ac0921b","source_id":"us-nc","stale":false,"prev":"us-nc/n.c.-gen.-stat.-90-113.75d","next":"us-nc/n.c.-gen.-stat.-90-113.76"},"notice":"GroundRules: Original legal text. Not legal advice."}